title: Altered bone turnover in chlorpromazine-challenged rats and its effect on 1alpha-hydroxyvitamin D3 administration in vivo.
abstract: We reported previously that Ca and Pi levels are elevated and alkaline phosphatase (ALP) activity and 1alpha,25(OH)2D3 levels are reduced in chlorpromazine (CPZ)-challenged rats. In the present study, we determined the serum levels of interleukin (IL)-6 and acid phosphatase (ACP) in CPZ-challenged rats, in addition to levels of ALP protein. ALP mRNA and coccyx morphology were examined in CPZ-challenged rats as well as the effect of CPZ on 1alpha(OH)D3 production in vivo. Although Ca, Pi, IL-6, and ACP activity levels in CPZ-challenged rats were markedly increased on day 30, the elevated serum levels were restored to within normal ranges by the in vivo addition of 1alpha(OH)D3 to CPZ administration. The gain in body weight in CPZ-treated rats was significantly improved by the addition of 1alpha(OH)D3. Reduced levels of 1alpha,25(OH)2D3 in CPZ-treated rats were restored to normal levels by the administration of 1alpha(OH)D3. Moreover, the decreased ALP activity and ALP mRNA levels in the rat coccyx marrow in CPZ-treated rats were also restored by the administration of 1alpha(OH)D3 with CPZ. However, the molecular sizes of rat ALP molecules and ALP mRNA were the same for each group. Furthermore, bone morphometry showed that trabecular bone in the rat coccyx was decreased in CPZ-treated rats. However, the reduced volume of trabecular bone in CPZ-treated rats was restored by the addition of 1alpha(OH)D3 to CPZ administration. Taken together, altered bone metabolism in CPZ-treated rats can be improved by the addition of 1alpha(OH)D3.
authors.affiliation: Department of Biochemistry, Saitama Medical School, Iruma-gun, Japan.
authors.forename: Koutaro
authors.initials: K
authors.lastname: Oh-ie
authors.forename: Takashi
authors.initials: T
authors.lastname: Miyazaki
authors.forename: Iwao
authors.initials: I
authors.lastname: Koyama
authors.forename: Shigeru
authors.initials: S
authors.lastname: Hokari
authors.forename: Tsugikazu
authors.initials: T
authors.lastname: Komoda
mesh_terms: D000135:Acid Phosphatase / Q000097:blood; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D001835:Body Weight; D001853:Bone Marrow / Q000201:enzymology; D016723:Bone Remodeling / Q000187:drug effects*; D002117:Calcitriol / Q000494:pharmacology*; D002118:Calcium / Q000097:blood; D002746:Chlorpromazine / Q000494:pharmacology*; D018492:Dopamine Antagonists / Q000494:pharmacology*; D004347:Drug Interactions; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D010710:Phosphates / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D018492:Dopamine Antagonists; D015850:Interleukin-6; D010710:Phosphates; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D002117:Calcitriol; D002118:Calcium; D002746:Chlorpromazine